Asimilobine
| Names | |
|---|---|
| IUPAC name
1-Methoxy-12-nor-6aβ-aporphin-2-ol | |
| Systematic IUPAC name
(6aR)-1-methoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-2-ol | |
| Other names
1857; (R)-Asimilobine; (R)-1-Methoxy-2-hydroxynoraporphine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C17H17NO2 | |
| Molar mass | 267.328 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Asimilobine, also known as (R)-1-methoxy-2-hydroxynoraporphine, is a noraporphine alkaloid with various known pharmacological actions. It has been found to act as a selective biased partial agonist of the serotonin 5-HT2C receptor, with an EC50 of 308 nM and Emax of 86% for activation of Gq signaling and no β-arrestin2 recruitment. Conversely, asimilobine was inactive as an agonist of the serotonin 5-HT2A and 5-HT2B receptors, but did show weak antagonism of these receptors at very high concentrations (IC50 = >10,000 nM). Derivatives and analogues of asimilobine with more potent serotonin 5-HT2C receptor agonism, such as 11-chloroasimilobine, have been studied and described. In addition, derivatives with dual highly potent serotonin 5-HT2A and 5-HT2C receptor agonism, such as 11-methoxyasimilobine, have been described.
Although asimilobine is inactive as an agonist of the serotonin 5-HT2A and 5-HT2C receptors, the racemic form of the compound has been found to act as an agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors, with EC50 (Emax) values of 318 nM (55%), 794 nM (25%), and 51 nM (94%), respectively. The 1-propoxy homologue shows more potent serotonin 5-HT2A and 5-HT2B receptor agonism and less potent serotonin 5-HT2C receptor agonism (EC50 (Emax) = 43 nM (91%), 53 nM (81%), and 197 nM (98%), respectively).